What is the best initial diagnostic study that should be used for a suspected osteomyelitis diagnosis? A critical review and clinical application of: Kapoor A, Page S, LaValley M, Gale DR, Felson DT. Magnetic resonance imaging for diagnosing foot osteomyelitis: a meta-analysis.
they were unable to meet the criteria mentioned above, or because a patient was reused in two studies. One study was also excluded that included a Charcot joint; this is important because in the article, the authors explain that MRI changes seen in osteomyelitis can be confused when a Charcot joint is present. This is an area of potential selection bias, which will be examined in detail later.
Critical Appraisal
This meta-analysis provides level 2a evidence using the Oxford and National Guidelines Clearinghouse criteria, because it provides data from cohort and randomized controlled trials. One of the advantages of this study is that it provides a cut-off point for the sensitivity of MRI, which is clinically relevant at 90%. It also provides receiver operator curves with relevant cut points and scales showing the area under curve (AUC) of MRI against the AUC of the three other tests. This kind of direct comparison makes it easy to see the global evidence and superiority of MRI graphically. The drawback of this technique is that it cannot determine the strengths and weaknesses of each individual data set, because it works as an average. A likelihood ratio matrix showing the strengths and weak-nesses of each individual study could strengthen this meta-analysis. Instead, the study uses diagnostic odds ratios, thus providing good evidence that the MRI is the best imaging technique to diagnose osteomyelitis of the foot and ankle in adults. Even in subsets that included different designs and more diverse patients, the superior performance of MRI remained statistically relevant. However, there are many flaws in this meta-analysis. For example, very few of the studies used in the meta-analysis followed up the MRI, and corroborated the evidence of osteomyelitis, with the gold standard of biopsy; thus, the comparison of MRI against other techniques for diagnosis was not entirely complete. Also, as noted earlier, the exclusion of documentation regarding Charcot foot is a potential confounding variable since this is often confused with osteomyelitis on MRI. It would be good to establish a best initial diagnostic procedure in this subset of patients.
The largest and most relevant study within this meta-analysis is by Ledermann et al. 1 , which uses standard primary signs (the presence of focally decreased marrow signal on T1 weighted images, and increased marrow signal on T2 weighted images), as well as many secondary signs like ulcers or cortical disruption, on MRI to determine a positive result. The positive likelihood ratio of this study is 5.62 and the negative likelihood ratio is 0.112. These numbers mean that when MRI is positive there is a moderate increase in the likelihood of having osteomyelitis, and when MRI is negative there is moderate-strong decrease in the likelihood of disease. 38 These data agree with the claim put forth in the meta-analysis.
Clinical Application
After reading this study, it makes sense that we ordered an MRI for my patient because it provides the best initial imaging to diagnose osteomyelitis. Before the MRI results were available, the patient was started on empiric antibiotics. Making a correct diagnosis is essential to avoid continuing antibiotics, which have potentially serious side effects if the patient does not have osteomyelitis. For this patient, the MRI was positive and was confirmed by bone biopsy done for culture and identification of the organism.
Three learning points to share:
1.) I learned that bone scans are inferior to MRI for diagnosing osteomyelitis because of excess false positive and false negative results.
2.) For my future career, I learned that I would not prescribe antibiotics to patients suspected of having osteomyelitis but who are clinically stable until the MRI results are available.
3.) I want to share with my peers that different consultants can give conflicting advice and that ultimately, we as the provider need the ability to make judgment calls regarding appropriate treatment and evaluation plans.
